Research Projects

Safer Scoring

Wireless wearables in high risk patients

This study is exploring whether wearable monitors, combined with advanced computer analysis, can detect early signs of serious illness before they become obvious to doctors or nurses. By identifying problems sooner, there may be more time to step in and provide treatment, which could improve patient outcomes.

We're using a wearable device from CheckPoint Cardio that continuously tracks vital signs like heart rate and temperature. This device has already been tested and validated in earlier international research. In this study, we’re focusing on patients receiving CAR-T therapy for lymphoma or leukaemia, as they are known to be at high risk of sudden deterioration.

Patients who agree to take part wear the device before their treatment begins and are monitored continuously for up to two weeks, or until they are admitted to intensive care or pass away. Their health data is monitored 24/7 by a remote team, who alert hospital staff if any concerning changes are picked up.

The device has already helped spot early warning signs like temperature spikes and heart rhythm changes, which in some cases have influenced how patients were treated. 

Lead Investigators

David Brealey